Importantly, Pro-IL-12 used in combination with an anti-PD-L1 antibody and a tyrosine kinase inhibitor (TKI) induced robust tumor regression in a TUBO model, a representative model of cold tumors, and an MC38 model (143). This evidence concerns the gene CD274 and neoplasm.